Skip to main content
Caplight Logo









Healshape

Healshape

Private
LyonHealthcare & Life Scienceshttps://healshape.com/

Last Round

Seed

Jun 28, 2022

Total Funding Raised

$6.3M

Company Overview

Healshape is a regenerative medicine company that develops 3D-bioprinted, personalized, and resorbable bioprostheses for soft tissue reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

breast reconstruction3D bioprintingregenerative medicinetissue engineeringbioprosthesisresorbable implantdissolvable implantsoft tissue reconstructiontissue scaffoldmastectomy reconstructiontissue regenerationmedical devicebio-inkhydrogellipofillingfat graftingnipple reconstruction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Healshape Comparables

Compare Healshape with similar companies based on industry and business-model similarity.

Healshape comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lattice Medical
88%
GenesisTissue Inc.
88%
BellaSeno
87%

Healshape Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 28, 2022
GrantJul 16, 2020
AcceleratorJan 28, 2020

Key People

Founding team and executive leadership

Amelie THEPOT

COO, Co-founder

Founding Team

Caroline Durand

Co-Founder - Chief Development Officer

Founding Team

MORGAN DOS SANTOS

Co-Founder I Special Advisor To The CEO

Founding Team

Sophie Brac de la Perrière

CEO

Executive Team

Healshape Investors

Notable investors and investment history

Healshape investors
InvestorRounds
Les Premières Auvergne-Rhône-AlpesAccelerator
GO CapitalSeed
Angels SantéSeed
PulsalysAccelerator
WinEquitySeed
Crédit Agricole CréationSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 5, 2024

    Grew 17% QoQ, from 18 to 21 employees.

  • Jun 28, 2022

    $6.3M round led by Demea Sustainable Investment and GO Capital.

Healshape Filings

Explore SEC and related filing metadata, where available.

Healshape filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Healshape's valuation, stock price, and market status.

Is Healshape a public or private company?

Healshape is a private company.

What is the current stock price of Healshape?

Healshape is a private company with no public stock price. No recent secondary market data is available.

How much is Healshape worth (valuation)?

Valuation information for Healshape is not publicly available.

Can I buy Healshape stock?

Healshape shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Healshape's last funding round?

Healshape's most recent funding round was Seed on June 28, 2022.

Who are the main investors in Healshape?

Key investors in Healshape include GO Capital, Pulsalys, Demea Sustainable Investment.

Will Healshape IPO soon?

No public IPO plans have been announced for Healshape.

How can I track Healshape secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Healshape's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLyon
Employee Range23
Year Founded2020
Last FundingJun 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?